SP2086
SP2086 is a pharmaceutical drug with 11 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
11
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Pharmacokinetics Study of Single and Multiple Dose of SP2086 in Healthy Volunteers
The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients
the Food Effect Pharmacokinetic, Material Balance and Metabolite Identification of SP2086 in Healthy Volunteers
The Metabolite Identification and Material Balance Study of SP2086
The DDI Study of SP2086 and Simvastatin
Clinical Trials (11)
The Pharmacokinetics Study of Single and Multiple Dose of SP2086 in Healthy Volunteers
The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients
the Food Effect Pharmacokinetic, Material Balance and Metabolite Identification of SP2086 in Healthy Volunteers
The Metabolite Identification and Material Balance Study of SP2086
The DDI Study of SP2086 and Simvastatin
The DDI Study of SP2086 and Valsartan
The Drug -Drug Interaction of SP2086 and Glyburide
SP2086 Pharmacokinetic Study in Renal Insufficiency Patients
The Drug-drug Interaction of SP2086 and Simvastatin
The Drug-drug Interaction of SP2086 and Valsartan
The Drug-drug Interaction of SP2086 and Metformin
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11